Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Surgery. 2017 Jan 9;161(5):1246–1254. doi: 10.1016/j.surg.2016.11.020

Table 1.

Success rates of patient-derived xenograft engraftment using the traditional xenograft method and the experimental fine needle aspirate method (TTF=time to tumor formation, FNA=fine needle aspirate).

Pancreas Melanoma Bladder NSCLC
Traditional xenograft growth (% success) 7/10 (70%) 5/11 (45.5%) 3/11 (27.3%) 8/17 (47.1%)
TTF in days (range) 41 (29–53) 39 (26–54) 74 (26–125) 58 (26–175)
Biopsy xenograft growth (% success) 3/9 (33.3%) 4/11 (36.4%) 0/11 (0%) 1/17 (5.8%)
TTF in days (range) 70 (39–147) 57 (46–85) N/A 60 (60)